357 related articles for article (PubMed ID: 33879826)
1. A systematic review and meta-analysis of geographic differences in comorbidities and associated severity and mortality among individuals with COVID-19.
Thakur B; Dubey P; Benitez J; Torres JP; Reddy S; Shokar N; Aung K; Mukherjee D; Dwivedi AK
Sci Rep; 2021 Apr; 11(1):8562. PubMed ID: 33879826
[TBL] [Abstract][Full Text] [Related]
2. Global prevalence and effect of comorbidities and smoking status on severity and mortality of COVID-19 in association with age and gender: a systematic review, meta-analysis and meta-regression.
Chenchula S; Vidyasagar K; Pathan S; Sharma S; Chavan MR; Bhagavathula AS; Padmavathi R; Manjula M; Chhabra M; Gupta R; Amerneni KC; Ghanta MK; Mudda S
Sci Rep; 2023 Apr; 13(1):6415. PubMed ID: 37076543
[TBL] [Abstract][Full Text] [Related]
3. The potential association between common comorbidities and severity and mortality of coronavirus disease 2019: A pooled analysis.
Luo L; Fu M; Li Y; Hu S; Luo J; Chen Z; Yu J; Li W; Dong R; Yang Y; Tu L; Xu X
Clin Cardiol; 2020 Dec; 43(12):1478-1493. PubMed ID: 33026120
[TBL] [Abstract][Full Text] [Related]
4. Age-related risk factors and severity of SARS-CoV-2 infection: a systematic review and meta-analysis.
Rahman MM; Bhattacharjee B; Farhana Z; Hamiduzzaman M; Chowdhury MAB; Hossain MS; Siddiqee MH; Islam MZ; Raheem E; Uddin MJ
J Prev Med Hyg; 2021 Jun; 62(2):E329-E371. PubMed ID: 34604574
[TBL] [Abstract][Full Text] [Related]
5. Mortality-related risk factors of COVID-19: a systematic review and meta-analysis of 42 studies and 423,117 patients.
Dessie ZG; Zewotir T
BMC Infect Dis; 2021 Aug; 21(1):855. PubMed ID: 34418980
[TBL] [Abstract][Full Text] [Related]
6. Comorbidities in SARS-CoV-2 Patients: a Systematic Review and Meta-Analysis.
Ng WH; Tipih T; Makoah NA; Vermeulen JG; Goedhals D; Sempa JB; Burt FJ; Taylor A; Mahalingam S
mBio; 2021 Feb; 12(1):. PubMed ID: 33563817
[TBL] [Abstract][Full Text] [Related]
7. Nervous system diseases are associated with the severity and mortality of patients with COVID-19: a systematic review and meta-analysis.
Gao Y; Chen Y; Liu M; Niu M; Song Z; Yan M; Tian J
Epidemiol Infect; 2021 Feb; 149():e66. PubMed ID: 33583450
[TBL] [Abstract][Full Text] [Related]
8. Prevalence and predictors of death and severe disease in patients hospitalized due to COVID-19: A comprehensive systematic review and meta-analysis of 77 studies and 38,000 patients.
Dorjee K; Kim H; Bonomo E; Dolma R
PLoS One; 2020; 15(12):e0243191. PubMed ID: 33284825
[TBL] [Abstract][Full Text] [Related]
9. Population risk factors for severe disease and mortality in COVID-19: A global systematic review and meta-analysis.
Booth A; Reed AB; Ponzo S; Yassaee A; Aral M; Plans D; Labrique A; Mohan D
PLoS One; 2021; 16(3):e0247461. PubMed ID: 33661992
[TBL] [Abstract][Full Text] [Related]
10. Cardio-Cerebrovascular Disease is Associated With Severity and Mortality of COVID-19: A Systematic Review and Meta-Analysis.
Yu JN; Wu BB; Yang J; Lei XL; Shen WQ
Biol Res Nurs; 2021 Apr; 23(2):258-269. PubMed ID: 32851851
[TBL] [Abstract][Full Text] [Related]
11. Epidemiological and clinical characteristics of cancer patients with COVID-19: A systematic review and meta-analysis of global data.
Kong X; Qi Y; Huang J; Zhao Y; Zhan Y; Qin X; Qi Z; Atanda AJ; Zhang L; Wang J; Fang Y; Jia P; Golozar A; Zhang L; Jiang Y
Cancer Lett; 2021 Jun; 508():30-46. PubMed ID: 33757803
[TBL] [Abstract][Full Text] [Related]
12. Epidemiology of COVID-19: A systematic review and meta-analysis of clinical characteristics, risk factors, and outcomes.
Li J; Huang DQ; Zou B; Yang H; Hui WZ; Rui F; Yee NTS; Liu C; Nerurkar SN; Kai JCY; Teng MLP; Li X; Zeng H; Borghi JA; Henry L; Cheung R; Nguyen MH
J Med Virol; 2021 Mar; 93(3):1449-1458. PubMed ID: 32790106
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of comorbidity in Chinese patients with COVID-19: systematic review and meta-analysis of risk factors.
Yin T; Li Y; Ying Y; Luo Z
BMC Infect Dis; 2021 Feb; 21(1):200. PubMed ID: 33618678
[TBL] [Abstract][Full Text] [Related]
14. Comorbidities associated with mortality in 31,461 adults with COVID-19 in the United States: A federated electronic medical record analysis.
Harrison SL; Fazio-Eynullayeva E; Lane DA; Underhill P; Lip GYH
PLoS Med; 2020 Sep; 17(9):e1003321. PubMed ID: 32911500
[TBL] [Abstract][Full Text] [Related]
15. COVID-19 and comorbidities: a systematic review and meta-analysis.
Gold MS; Sehayek D; Gabrielli S; Zhang X; McCusker C; Ben-Shoshan M
Postgrad Med; 2020 Nov; 132(8):749-755. PubMed ID: 32573311
[TBL] [Abstract][Full Text] [Related]
16. Cardiovascular comorbidities as predictors for severe COVID-19 infection or death.
Phelps M; Christensen DM; Gerds T; Fosbøl E; Torp-Pedersen C; Schou M; Køber L; Kragholm K; Andersson C; Biering-Sørensen T; Christensen HC; Andersen MP; Gislason G
Eur Heart J Qual Care Clin Outcomes; 2021 Mar; 7(2):172-180. PubMed ID: 33107909
[TBL] [Abstract][Full Text] [Related]
17. COVID-19 mortality effects of underlying health conditions in India: a modelling study.
Novosad P; Jain R; Campion A; Asher S
BMJ Open; 2020 Dec; 10(12):e043165. PubMed ID: 33328263
[TBL] [Abstract][Full Text] [Related]
18. COVID-19 and geographical area of origin.
Norman FF; Crespillo-Andújar C; Pérez-Molina JA; Comeche B; Chamorro S; Monge-Maillo B; Moreno-Guillén S; López-Vélez R;
Clin Microbiol Infect; 2021 Apr; 27(4):632.e1-632.e5. PubMed ID: 33246039
[TBL] [Abstract][Full Text] [Related]
19. Impact of cardiovascular diseases on severity of COVID-19 patients: A systematic review.
Mishra P; Parveen R; Bajpai R; Samim M; Agarwal NB
Ann Acad Med Singap; 2021 Jan; 50(1):52-60. PubMed ID: 33623958
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of comorbidities in patients and mortality cases affected by SARS-CoV2: a systematic review and meta-analysis.
Espinosa OA; Zanetti ADS; Antunes EF; Longhi FG; Matos TA; Battaglini PF
Rev Inst Med Trop Sao Paulo; 2020; 62():e43. PubMed ID: 32578683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
